Opthea Ltd logo

Opthea Ltd - ADR

NEW
NAS:OPT (Australia)   ADR
$ 3.07 -0.10 (-3.15%) 07:08 PM EST
At Loss
Market Cap:
$ 465.35M
Enterprise V:
$ 505.84M
Volume:
15.46K
Avg Vol (2M):
41.80K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
15.46K
At Loss
Avg Vol (2M):
41.80K

Business Description

Description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.84
Equity-to-Asset -1.16
Debt-to-Equity -0.93
Debt-to-EBITDA -0.73
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.85
Distress
Grey
Safe
Beneish M-Score -2.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.57
Quick Ratio 1.57
Cash Ratio 1.44
Days Sales Outstanding 5504.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.2
Shareholder Yield % -49.83
Name Current Vs Industry Vs History
Operating Margin % -210542.54
Net Margin % -288689.55
FCF Margin % -82510.23
ROA % -152.05
ROIC % -573.96
3-Year ROIIC % -1369.83
ROC (Joel Greenblatt) % -202849.2
ROCE % -214.33

Financials (Next Earnings Date:2025-08-29 Est.)

OPT's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OPT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Opthea Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.088
EPS (TTM) ($) -2.252
Beta 1.43
3-Year Sharpe Ratio 0.19
3-Year Sortino Ratio 0.32
Volatility % 84.74
14-Day RSI 33.57
14-Day ATR ($) 0.510109
20-Day SMA ($) 4.62417
12-1 Month Momentum % 54.03
52-Week Range ($) 1.79 - 6.3
Shares Outstanding (Mil) 153.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Opthea Ltd Filings

Filing Date Document Date Form
No Filing Data

Opthea Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Opthea Ltd Frequently Asked Questions

What is Opthea Ltd(OPT)'s stock price today?
The current price of OPT is $3.07. The 52 week high of OPT is $6.30 and 52 week low is $1.79.
When is next earnings date of Opthea Ltd(OPT)?
The next earnings date of Opthea Ltd(OPT) is 2025-08-29 Est..
Does Opthea Ltd(OPT) pay dividends? If so, how much?
Opthea Ltd(OPT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1